Han Liang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Ulcerative Colitis

Epidermal Growth Factor Receptor

Top Venues

British journal of cancer

Cancer communications (London, England)

Cell death & disease

Technology in cancer research & treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer 130 (4) (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer 130 (4) (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer 130 (4) (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer 130 (4) (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer 130 (4) (2024)
Fenglin Cai, Xiuding Yang, Gang Ma, Pengliang Wang, Mengmeng Zhang, Nannan Zhang, Rupeng Zhang, Han Liang, Yongzhan Nie, Cheng Dong, Jingyu Deng
EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British journal of cancer 130 (4) (2024)
Yi Zeng, Gang Ma, Fenglin Cai, Pengliang Wang, Han Liang, Rupeng Zhang, Jingyu Deng, Yong Liu
SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner. Cell death & disease 14 (6) (2023)
Yi Zeng, Gang Ma, Fenglin Cai, Pengliang Wang, Han Liang, Rupeng Zhang, Jingyu Deng, Yong Liu
SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner. Cell death & disease 14 (6) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) (2023)
Yi Zeng, Gang Ma, Fenglin Cai, Pengliang Wang, Han Liang, Rupeng Zhang, Jingyu Deng, Yong Liu
SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner. Cell death & disease 14 (6) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) 44 (1) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) 44 (1) (2023)
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai, Yuan-Fang Li, Xiu-Juan Qu, Hong Qiu, Yu-Jing Zhang, Jie-Er Ying, Jun Zhang, Ling-Yu Sun, Rong-Bo Lin, Chang Wang, Hao Liu, Miao-Zheng Qiu, Wen-Long Guan, Sheng-Xiang Rao, Jia-Fu Ji, Yan Xin, Wei-Qi Sheng, Hui-Mian Xu, Zhi-Wei Zhou, Ai-Ping Zhou, Jing Jin, Xiang-Lin Yuan, Feng Bi, Tian-Shu Liu, Han Liang, Yan-Qiao Zhang, Guo-Xin Li, Jun Liang, Bao-Rui Liu, Lin Shen, Jin Li, Rui-Hua Xu
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer communications (London, England) 44 (1) (2023)
Weilin Sun, Gang Ma, Li Zhang, Pengliang Wang, Nannan Zhang, Zizhen Wu, Yinping Dong, Fenglin Cai, Liqiao Chen, Huifang Liu, Han Liang, Jingyu Deng
DNMT3A-mediated silence in ADAMTS9 expression is restored by RNF180 to inhibit viability and motility in gastric cancer cells. Cell death & disease 12 (5) (2021)
Ming-Zhi Cai, Shao-Yan Wen, Xue-Jun Wang, Yong Liu, Han Liang
MYC Regulates PHF8, Which Promotes the Progression of Gastric Cancer by Suppressing miR-22-3p. Technology in cancer research & treatment 19 (2021)